Cargando…

Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions

INTRODUCTION: The development of an effective therapeutic HIV vaccine that induces immunologic control of viral replication, thereby eliminating or reducing the need for antiretroviral therapy (ART), would be of great value. Besides the obvious challenges of developing a therapeutic vaccine that wou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graziani, Gina M, Angel, Jonathan B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641978/ https://www.ncbi.nlm.nih.gov/pubmed/26561337 http://dx.doi.org/10.7448/IAS.18.1.20497

Ejemplares similares

Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial
por: Li, Jonathan Z., et al.
Publicado: (2012)

The Effect of Therapeutic HIV Vaccination With ALVAC-HIV With or Without Remune on the Size of the Viral Reservoir (A CTN 173 Substudy)
por: Angel, Jonathan B., et al.
Publicado: (2015)

Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations
por: Zheng, Lu, et al.
Publicado: (2021)

Imaging and biopsy of HIV-infected individuals undergoing analytic treatment interruption
por: Lau, Chuen-Yen, et al.
Publicado: (2022)

From early AIDS vaccine to HIV cure research with analytical treatment interruption trials: a study participant testimonial
por: Freshwater, William
Publicado: (2019)

Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption
por: Wang, Xiaolei, et al.
Publicado: (2021)

A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption
por: Peluso, Michael J, et al.
Publicado: (2020)

Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients
por: Fehér, Csaba, et al.
Publicado: (2019)

Impact of Analytical Treatment Interruption on Burden and Diversification of HIV Peripheral Reservoir: A Pilot Study
por: Scutari, Rossana, et al.
Publicado: (2021)

Antiretroviral therapy interruptions: impact on HIV treatment and transmission
por: Dubrocq, Gueorgui, et al.
Publicado: (2018)

Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals
por: Clarridge, Katherine E., et al.
Publicado: (2018)

Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response
por: Leal, Lorna, et al.
Publicado: (2020)

Treatment Interruptions in Chronic HIV Infection
Publicado: (2004)

Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
por: Vibholm, Line K., et al.
Publicado: (2019)

Extensive characterization of HIV-1 reservoirs reveals links to plasma viremia before and during analytical treatment interruption
por: Cole, Basiel, et al.
Publicado: (2022)

Interrupting antiretroviral treatment in HIV cure research: scientific and ethical considerations
por: Garner, Samual A, et al.
Publicado: (2017)

Eradication of HIV-1 latent reservoirs through therapeutic vaccination
por: Pankrac, Joshua, et al.
Publicado: (2017)

Reconsidering Early HIV Treatment and Supervised Treatment Interruptions
por: Koup, Richard A
Publicado: (2004)

Evaluating lncRNA Expression Patterns during HIV-1 Treatment Interruption
por: Schynkel, Tinus, et al.
Publicado: (2023)

Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on‐going viral transcription
por: Pannus, Pieter, et al.
Publicado: (2020)

Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B
por: Rosás-Umbert, Miriam, et al.
Publicado: (2017)

Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
por: Giron, Leila B., et al.
Publicado: (2021)

The Effect of HIV Treatment Interruption on Subsequent Immunological Response
por: Thomadakis, Christos, et al.
Publicado: (2023)

Participant experiences using novel home-based blood collection device for viral load testing in the HIV cure trials with analytical treatment interruptions
por: Dubé, Karine, et al.
Publicado: (2022)

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
por: Tomaras, Georgia D., et al.
Publicado: (2013)

A15 HIV-1 whole-genome NGS analysis to characterize virus evolution following dendritic cell immunotherapy and analytical treatment interruption
por: Lungu, C, et al.
Publicado: (2018)

Supervised Treatment Interruptions Fail to Control HIV-1 Viremia
Publicado: (2004)

On the role of resonance in drug failure under HIV treatment interruption
por: Oña, Leonardo, et al.
Publicado: (2013)

Feasible, Efficient and Necessary, without Exception – Working with Sex Workers Interrupts HIV/STI Transmission and Brings Treatment to Many in Need
por: Steen, Richard, et al.
Publicado: (2015)

Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
por: Hurst, Jacob, et al.
Publicado: (2015)

Recruitment and ethical considerations in HIV cure trials requiring treatment interruption
por: Arnold, Michael P, et al.
Publicado: (2015)

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption
por: Rockstroh, Jürgen K., et al.
Publicado: (2019)

The Immunological and Virological Consequences of Planned Treatment Interruptions in Children with HIV Infection
por: Klein, Nigel, et al.
Publicado: (2013)

Preventing Antiretroviral Treatment Interruptions among HIV/AIDS Patients in Africa
por: Mills, Edward J., et al.
Publicado: (2013)

Risk to Nonparticipants in HIV Remission Studies With Treatment Interruption: A Symposium
por: Eyal, Nir, et al.
Publicado: (2019)

“It comes altogether as one:” perceptions of analytical treatment interruptions and partner protections among racial, ethnic, sex and gender diverse HIV serodifferent couples in the United States
por: Campbell, Danielle M., et al.
Publicado: (2022)

Interrupting Neuron—Tumor Interactions to Overcome Treatment Resistance
por: Hunt, Patrick J., et al.
Publicado: (2020)

Longitudinal changes in HIV-specific IFN-γ secretion in subjects who received Remune™ vaccination prior to treatment interruption
por: Huang, Kenneth H, et al.
Publicado: (2006)

Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment Interruption
por: Park, You Jeong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_as73qtq4qtveh9h1tomejjojjg